Role of F-fluoro-2-deoxyglucose Positron Emission Tomography in Gastric GIST: Predicting Malignant Potential Pre-operatively
- PMID: 22076223
- PMCID: PMC3204465
- DOI: 10.5230/jgc.2011.11.3.173
Role of F-fluoro-2-deoxyglucose Positron Emission Tomography in Gastric GIST: Predicting Malignant Potential Pre-operatively
Abstract
Purpose: It is difficult to obtain biopsies from gastrointestinal stromal tumors (GISTs) prior to surgery because GISTs are submucoal tumors, despite being the most common nonepithelial neoplasms of the gastrointestinal tract. Unlike anatomic imaging techniques, PET-CT, which is a molecular imaging tool, can be a useful technique for assessing tumor activity and predicting the malignant potential of certain tumors. Thus, we aimed to evaluate the usefulness of PET-CT as a pre-operative prognostic factor for GISTs by analyzing the correlation between the existing post-operative prognostic factors and the maximum SUV uptake (SUVmax) of pre-operative 18F-fluoro-2-deoxyglucose (FDG) PET-CT.
Materials and methods: The study was conducted on 26 patients who were diagnosed with gastric GISTs and underwent surgery after being examined with pre-operative FDG PET-CT. An analysis of the correlation bewteen (i) NIH risk classfication and the Ki-67 proliferation index, which are post-operative prognostic factors, and (ii) the SUVmax of PET-CT, which is a pre-operative prognostic factor, was performed.
Results: There were significant correlations between (i) SUVmax and (ii) Ki-67 index, tumor size, mitotic count, and NIH risk group (r=0.854, 0.888, 0.791, and 0.756, respectively). The optimal cut-off value for SUVmax was 3.94 between "low-risk malignancy" and "high-risk malignancy" groups. The sensitivity and specificity of SUVmax for predicting the risk of malignancy were 85.7% and 94.7%, respectively.
Conclusions: The SUVmax of PET-CT is associated with Ki-67 index, tumor size, mitotic count, and NIH classification. Therefore, it is believed that PET-CT is a relatively safe, non-invasive diagnostic tool for assessing malignant potential pre-operatively.
Keywords: FDG PET-CT; GIST; Ki-67 index; Maximum SUV uptake; NIH classification.
Figures


Similar articles
-
The usefulness of preoperative 18FDG positron-emission tomography and computed tomography for predicting the malignant potential of gastrointestinal stromal tumors.Dig Surg. 2014;31(2):79-86. doi: 10.1159/000357149. Epub 2014 Apr 23. Dig Surg. 2014. PMID: 24776690
-
[The value of (18)F-FDG PET-CT imaging in predicting the malignant potential of GIST].Zhonghua Zhong Liu Za Zhi. 2017 Nov 23;39(11):821-827. doi: 10.3760/cma.j.issn.0253-3766.2017.11.004. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 29151288 Chinese.
-
Value of 18F-FDG PET/CT for differentiating diagnosis between malignant and benign primary gastric gastrointestinal mesenchymal tumors: a single-center retrospective study.J Gastrointest Oncol. 2022 Apr;13(2):637-646. doi: 10.21037/jgo-22-287. J Gastrointest Oncol. 2022. PMID: 35557562 Free PMC article.
-
Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.Hell J Nucl Med. 2013 May-Aug;16(2):97-102. doi: 10.1967/s002449910084. Epub 2013 May 20. Hell J Nucl Med. 2013. PMID: 23687644 Review.
-
Performance of F-18 FDG PET/CT for predicting malignant potential of gastrointestinal stromal tumors: A systematic review and meta-analysis.J Gastroenterol Hepatol. 2018 Mar;33(3):576-582. doi: 10.1111/jgh.14015. J Gastroenterol Hepatol. 2018. PMID: 28994187
Cited by
-
Correlation between the Uptake of 18F-Fluorodeoxyglucose (18F-FDG) and the Expression of Proliferation-Associated Antigen Ki-67 in Cancer Patients: A Meta-Analysis.PLoS One. 2015 Jun 3;10(6):e0129028. doi: 10.1371/journal.pone.0129028. eCollection 2015. PLoS One. 2015. PMID: 26038827 Free PMC article.
-
Comparative Oncology: Evaluation of 2-Deoxy-2-[18F]fluoro-D-glucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) for the Staging of Dogs with Malignant Tumors.PLoS One. 2015 Jun 12;10(6):e0127800. doi: 10.1371/journal.pone.0127800. eCollection 2015. PLoS One. 2015. PMID: 26068641 Free PMC article.
-
PET-Negative Gastrointestinal Stromal Tumors.Case Rep Oncol. 2013 Oct 5;6(3):508-13. doi: 10.1159/000355432. eCollection 2013. Case Rep Oncol. 2013. PMID: 24403895 Free PMC article.
-
Diagnostic Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Gastric Mesenchymal Tumors.J Clin Med. 2020 May 1;9(5):1301. doi: 10.3390/jcm9051301. J Clin Med. 2020. PMID: 32370028 Free PMC article.
-
The predictive value of preoperative 18F-fluorodeoxyglucose PET for postoperative recurrence in patients with localized primary gastrointestinal stromal tumour.Eur Radiol. 2016 Dec;26(12):4664-4674. doi: 10.1007/s00330-016-4242-5. Epub 2016 Feb 6. Eur Radiol. 2016. PMID: 26852217
References
-
- Miettinen M, Majidi M, Lasota J. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur J Cancer. 2002;38(Suppl 5):S39–S51. - PubMed
-
- Miettinen M, Lasota J. Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch. 2001;438:1–12. - PubMed
-
- Nakahara M, Isozaki K, Hirota S, Miyagawa J, Hase-Sawada N, Taniguchi M, et al. A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors. Gastroenterology. 1998;115:1090–1095. - PubMed
-
- Taniguchi M, Nishida T, Hirota S, Isozaki K, Ito T, Nomura T, et al. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Res. 1999;59:4297–4300. - PubMed
LinkOut - more resources
Full Text Sources